CAC
EUCR

Cowen and Company’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Cowen and Company’s Portfolio EUCR Stock Details EUCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-65,296
Closed -$652K – 550
2021
Q1 		$652K Buy
+65,296
New +$652K 0.04% 154